Company Avicanna Inc.

Equities

AVCN

CA05368K1003

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 15:59:58 2024-05-03 EDT			5-day change	1st Jan Change
0.35 ^CAD	0.00%		+2.94%	0.00%

04-19	Avicanna Raises About $2.1 Million in Non-brokered Private Placement	MT
04-18	Avicanna Inc. announced that it has received CAD 2.125584 million in funding	CI

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including oral, sublingual, topical and transdermal delivery. It has developed a pipeline of patent-pending drug candidates that are indication specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain and various neurological disorders. Its first pharmaceutical preparation (Trunerox) is in the drug registration stage in South America. MyMedi.ca is a medical cannabis care platform that serves medical cannabis patientsâ needs and enhances the patient's journey.

Number of employees: 87

CAD in Million	2022	Weight	2023	Weight	Delta
Plant-derived Cannabinoid-based Product 96.8 %	3	69.7 %	16	96.8 %	+476.16%
License 2.5 %	1	27.3 %	0	2.5 %	-62.40%
Service 0.7 %	0	3.0 %	0	0.7 %	+0.49%

CAD in Million	2022	Weight	2023	Weight	Delta
North America 97.8 %	3	73.7 %	16	97.8 %	+450.83%
South America 2.2 %	1	25.5 %	0	2.2 %	-64.63%

Managers	Title	Age	Since
Aras Azadian FOU	Founder	37	15-04-30
Phillip Cardella DFI	Director of Finance/CFO	-	-
Karolina Urban CTO	Chief Tech/Sci/R&D Officer	-	-
Roland Alvarez CTO	Chief Tech/Sci/R&D Officer	-	18-02-28
Ingrid Diaz CMP	Compliance Officer	-	-
Stephen Kim LAW	General Counsel	-	22-01-16
Samantha Watt PRN	Corporate Officer/Principal	-	16-10-31
Ivana Maric SAM	Sales & Marketing	-	15-04-30

Members of the board	Title	Age	Since
Paul Fornazzari BRD	Director/Board Member	57	11-12
Aras Azadian FOU	Founder	37	15-04-30
John McVicar BRD	Director/Board Member	-	21-06-23
Eileen McCormack BRD	Director/Board Member	-	22-01-03
Giancarlo Davila Char BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	97,601,896	81,464,191 ( 83.47 %)	0	83.47 %

Name	Equities	%	Valuation
THREED CAPITAL INC. 6.156 %	5,398,300	6.156 %	2 M $
Sheldon Inwentash 5.967 %	5,232,550	5.967 %	2 M $
Aras Azadian 4.053 %	3,553,927	4.053 %	1 M $
Giancarlo Davila Char 2.407 %	2,110,348	2.407 %	827 256 $
Phillip Cardella 0.5160 %	452,434	0.5160 %	177 354 $
Chandrakant Panchal 0.3330 %	291,959	0.3330 %	114 448 $
John McVicar 0.3156 %	276,722	0.3156 %	108 475 $
Eileen McCormack 0.0806 %	70,644	0.0806 %	27 692 $
Paul Fornazzari 0.000000 %	0	0.000000 %	- $

Avicanna, Inc.

480 University Avenue Suite 1502

M5G 1V2, Toronto

http://www.avicanna.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
AVICANNA INC.	0.00%	24.93M
MODERNA, INC.	+25.69%	48.09B
LONZA GROUP AG	+46.90%	40.62B
IQVIA HOLDINGS INC.	-3.46%	40.43B
CELLTRION, INC.	-6.20%	28.36B
ICON PUBLIC LIMITED COMPANY	+9.17%	24.89B
ALNYLAM PHARMACEUTICALS, INC.	-20.42%	19.01B
MEDPACE HOLDINGS, INC.	+28.07%	12.09B
BIO-TECHNE CORPORATION	+0.17%	11.88B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.24%	11.8B

Other Biotechnology & Medical Research